Free Trial

Molecular Partners (MLLCF) Short Interest Ratio & Short Volume

Molecular Partners logo
$4.22 -0.06 (-1.40%)
As of 09:57 AM Eastern

Molecular Partners Short Interest Data

Molecular Partners (MLLCF) has a short interest of 52,600 shares. This marks a -0.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 175.3, indicating that it would take 175.3 days of the average trading volume of 546 shares to cover all short positions.

Current Short Interest
52,600 shares
Previous Short Interest
52,900 shares
Change Vs. Previous Month
-0.57%
Dollar Volume Sold Short
$237,226.00
Short Interest Ratio
175.3 Days to Cover
Last Record Date
January 15, 2025
Today's Trading Volume
183 shares
Average Trading Volume
546 shares
Today's Volume Vs. Average
34%
Short Selling Molecular Partners?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Molecular Partners and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MLLCF Short Interest Over Time

MLLCF Days to Cover Over Time

MLLCF Percentage of Float Shorted Over Time

Molecular Partners Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/202552,600 shares $237,226.00 -0.6%N/A175.3 $4.51
12/31/202452,900 shares $217,419.00 -10.6%N/A264.5 $4.11
12/15/202459,200 shares $269,360.00 -5.6%N/A98.7 $4.55
11/30/202462,700 shares $284,031.00 +10.8%N/A627 $4.53
11/15/202456,600 shares $283,000.00 +8.9%N/A566 $5.00
10/31/202452,000 shares $330,200.00 +3.8%N/A520 $6.35
10/15/202450,100 shares $225,450.00 No ChangeN/A501 $4.50
9/30/202450,100 shares $295,089.00 No ChangeN/A0 $5.89
9/15/202450,100 shares $295,089.00 -9.6%N/A0 $5.89
8/31/202455,400 shares $326,306.00 -3.0%N/A554 $5.89
8/15/202457,100 shares $336,319.00 +4.4%N/A0 $5.89
7/31/202454,700 shares $322,183.00 +5.2%N/A547 $5.89
7/15/202452,000 shares $339,040.00 -16.0%N/A520 $6.52
6/30/202461,900 shares $612,810.00 +16.8%N/A619 $9.90
6/15/202453,000 shares $264,470.00 +6.0%N/A264.9 $4.99
5/31/202450,000 shares $183,000.00 No ChangeN/A500 $3.66
5/15/202450,000 shares $190,000.00 -27.0%N/A0 $3.80
4/30/202468,500 shares $260,300.00 No ChangeN/A0 $3.80
4/15/202468,500 shares $260,300.00 -1.2%N/A342.5 $3.80
3/31/202469,300 shares $284,130.00 -0.3%N/A693 $4.10
3/15/202469,500 shares $284,950.00 -0.9%N/A695 $4.10
2/29/202470,100 shares $297,925.00 +0.1%N/A233.7 $4.25
2/15/202470,000 shares $287,000.00 -1.4%N/A700 $4.10
1/15/202471,700 shares $293,970.00 -8.9%N/A9.1 $4.10
12/31/202378,700 shares $338,410.00 -3.9%N/A88 $4.30
12/15/202381,900 shares $331,695.00 -2.3%N/A45.5 $4.05
11/30/202383,800 shares $329,334.00 -1.1%N/A16.4 $3.93
11/15/202384,700 shares $334,565.00 +2.1%N/A2.4 $3.95
10/31/202383,000 shares $282,200.00 No ChangeN/A276.7 $3.40
10/15/202383,000 shares $361,050.00 No ChangeN/A0 $4.35
9/30/202383,000 shares $361,050.00 -9.9%N/A415 $4.35
9/15/202392,100 shares $468,789.00 +53.2%N/A307 $5.09
8/31/202360,100 shares $345,575.00 +1.5%N/A509.6 $5.75
8/15/202359,200 shares $349,280.00 -21.8%N/A49.3 $5.90
7/31/202375,700 shares $505,676.00 -1.6%N/A12 $6.68
7/15/202376,900 shares $503,695.00 +3.1%N/A384.5 $6.55
6/30/202374,600 shares $442,378.00 +1.6%N/A186.5 $5.93
6/15/202373,400 shares $462,420.00 -0.8%N/A367 $6.30
5/31/202374,000 shares $487,660.00 -0.4%N/A740 $6.59
5/15/202374,300 shares $468,090.00 +2.6%N/A92.9 $6.30
Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.
4/30/202372,400 shares $471,686.00 +1.1%N/A724 $6.52
4/15/202371,600 shares $393,084.00 -0.1%N/A358 $5.49
3/31/202371,700 shares $410,124.00 -2.9%N/A717 $5.72
3/15/202373,800 shares $402,210.00 -17.8%N/A738 $5.45
2/28/202389,800 shares $520,840.00 -6.6%N/A898 $5.80
2/15/202396,100 shares $576,600.00 +27.5%N/A480.5 $6.00
1/31/202375,400 shares $487,084.00 +2.7%N/A754 $6.46
1/15/202373,400 shares $443,336.00 +3.1%N/A734 $6.04
12/30/202271,200 shares $439,304.00 -37.2%N/A101.7 $6.17
12/15/2022113,400 shares $708,466.50 -30.0%N/A226.8 $6.25
11/30/2022162,100 shares $1.05 million -12.5%N/A1621 $6.45
11/15/2022185,300 shares $1.19 million -14.3%N/A1853 $6.41
10/31/2022216,100 shares $1.39 million +5.9%N/A1080.5 $6.41
10/15/2022204,000 shares $1.28 million +18.7%N/A2040 $6.29
9/30/2022171,900 shares $1.08 million +36.4%N/A429.8 $6.29
9/15/2022126,000 shares $734,580.00 -6.4%N/A420 $5.83
8/31/2022134,600 shares $745,011.00 +1.2%N/A269.2 $5.54
8/15/2022133,000 shares $758,100.00 -7.5%N/A665 $5.70
7/31/2022143,800 shares $805,280.00 -13.7%N/A239.7 $5.60
7/15/2022166,700 shares $1.23 million -4.8%N/A416.8 $7.35
6/30/2022175,100 shares $1.01 million -4.0%N/A175.1 $5.79
6/15/2022182,300 shares $995,358.00 +10.2%N/A182.3 $5.46
5/31/2022165,400 shares $1.10 million +18.5%N/A413.5 $6.65
5/15/2022139,600 shares $738,484.00 +72.4%N/A465.3 $5.29
4/30/202281,000 shares $660,150.00 -9.8%N/A162 $8.15
4/15/202289,800 shares $1.83 million -7.1%N/A898 $20.40
3/31/202296,700 shares $1.97 million +33.2%N/A967 $20.40
3/15/202272,600 shares $1.82 million -27.3%N/A145.2 $25.00
2/28/202299,900 shares $2.30 million +40.3%N/A249.8 $23.00
2/15/202271,200 shares $1.85 million +58.2%N/A101.7 $26.00
1/31/202245,000 shares $1.22 million -48.6%N/A10.2 $27.00
1/15/202287,500 shares $2.80 million -31.5%N/A11.5 $32.00
12/31/2021127,800 shares $2.53 million +10.5%N/A63.9 $19.79
12/15/2021115,700 shares $1.73 million +126.0%N/A192.8 $14.95
11/30/202151,200 shares $602,112.00 -36.0%N/A2.7 $11.76
11/15/202180,000 shares $1.13 million -14.8%N/A8.6 $14.10
10/29/202193,900 shares $1.81 million -6.8%N/A234.8 $19.28
10/15/2021100,700 shares $1.95 million +18.6%N/A77.5 $19.35
9/30/202184,900 shares $1.57 million -2.8%N/A36.9 $18.45
9/15/202187,300 shares $1.65 million +47.2%N/A145.5 $18.88
8/31/202159,300 shares $1.23 million -46.7%N/A74.1 $20.73
8/13/2021111,300 shares $2.12 million -7.9%N/A139.1 $19.01
7/30/2021120,900 shares $2.39 million -28.3%N/A26.3 $19.75
7/15/2021168,700 shares $3.19 million +7.3%N/A54.4 $18.92
6/30/2021157,200 shares $3.10 million +120.2%N/A31.4 $19.70
6/15/202171,400 shares $1.69 million -26.2%N/A24.6 $23.69
5/28/202196,800 shares $2.75 million -0.5%N/A26.9 $28.40
5/14/202197,300 shares $2.18 million -3.5%N/A6.9 $22.40
4/30/2021100,800 shares $2.47 million -1.2%N/A21.9 $24.54
4/15/2021102,000 shares $2.53 million -5.5%N/A23.2 $24.78
Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.
3/31/2021107,900 shares $2.63 million +13.3%N/A12.3 $24.38
3/15/202195,200 shares $2.17 million +10.6%N/A6.1 $22.77
2/26/202186,100 shares $2.26 million -3.2%N/A18.7 $26.26
2/12/202188,900 shares $2.87 million -4.6%N/A8.9 $32.25
1/29/202193,200 shares $2.25 million -1.2%N/A10.4 $24.15
1/15/202194,600 shares $2.19 million -3.8%N/A7.9 $23.20
12/31/202092,100 shares $2.14 million -2.6%N/A9.5 $23.20
12/15/202094,600 shares $2.28 million -3.8%N/A7.9 $24.10
11/30/202098,300 shares $2.37 million -12.2%N/A4.4 $24.06
11/15/2020112,000 shares $2.64 million +7.7%N/A4.7 $23.57
10/30/2020104,000 shares $2.20 million -25.5%N/A1.8 $21.15
10/15/2020139,500 shares $2.33 million -18.7%N/A16.8 $16.73
9/30/2020171,600 shares $3.02 million +17.2%N/A32.4 $17.60
9/15/2020146,400 shares $2.63 million +15.2%N/A15.6 $17.99
8/31/2020127,100 shares $2.86 million -14.5%N/A22.7 $22.49
8/14/2020148,600 shares $3.42 million +36.1%N/A13.2 $23.00
7/31/2020109,200 shares $2.10 million +36.5%N/A5.4 $19.20
7/15/202080,000 shares $1.68 million -85.8%N/A1.8 $21.00
6/30/2020562,000 shares $12.65 million -6.7%N/A0 $22.50
6/15/2020602,200 shares $13.55 million +8.9%N/A6022 $22.50
5/29/2020552,800 shares $12.44 million No ChangeN/A0 $22.50
5/15/2020552,800 shares $12.44 million +56.2%N/A5528 $22.50
4/30/2020353,900 shares $7.96 million +19.6%N/A3539 $22.50
4/15/2020296,000 shares $6.66 million No ChangeN/A0 $22.50
3/31/2020296,000 shares $0.00 No ChangeN/A2960 $0.00
3/13/2020296,000 shares $6.66 million -20.8%N/A0 $22.50
2/28/2020373,700 shares $8.41 million -37.6%N/A1245.7 $22.50
2/14/2020599,100 shares $13.48 million -0.8%N/A5991 $22.50
1/31/2020604,000 shares $0.00 No ChangeN/A0 $0.00

MLLCF Short Interest - Frequently Asked Questions

What is Molecular Partners' current short interest?

Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 52,600 shares of MLLCF short. Learn More on Molecular Partners' current short interest.

What is a good short interest ratio for Molecular Partners?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MLLCF shares currently have a short interest ratio of 175.0. Learn More on Molecular Partners's short interest ratio.

Is Molecular Partners' short interest increasing or decreasing?

Molecular Partners saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 52,600 shares, a decline of 0.6% from the previous total of 52,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Molecular Partners stock?

Short selling MLLCF is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Molecular Partners?

A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MLLCF, which in turn drives the price of the stock up even further.

How often is Molecular Partners' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MLLCF, twice per month. The most recent reporting period available is January, 15 2025.




This page (OTCMKTS:MLLCF) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners